Regranex is being studied by the FDA on whether it is linked to higher rates of cancer.
Is Regranex (becaplermin, Johnson & Johnson) Gel, which helps heal foot and leg diabetic ulcers, associated with higher rates of cancer death? That?s what the Food & Drug Administration is now studying. In an early company.
To see more Daily News articles, click here.
To go to the Drug Topics homepage, clickhere.
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.